Medical Communications

Showing 15 posts of 6408 posts found.

NICE opts to reject Celgene’s Revlimid for newly diagnosed multiple myeloma after an autologous stem cell transplant

September 11, 2020 Medical Communications, Sales and Marketing Celgene, NICE, Revlimid

It has emerged that NICE has opted to reject Celgene’s Revlimid (lenalidomide) for the maintenance of newly diagnosed multiple myeloma …
fda_21

FDA sends warning letters to websites illegally selling opioids

September 11, 2020 Medical Communications

The FDA has issued warning letters to 17 websites for illegally selling unapproved or misbranded opioids.  This is due to …
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

September 11, 2020 Medical Communications COVID-19, coronavirus, vaccines

The top 10 news stories this week largely cover COVID-19 vaccines, as hundreds of thousands of people in China have …
bob_woodward_meets_with_edward_r

President Trump has misled the public on how deadly COVID-19 is, according to Watergate reporter’s tapes

September 10, 2020 Medical Communications All the President's men, Bob Woodward, Trump, Watergate

President Trump knew how much more deadly coronavirus was than the flu, despite public comments saying that the threat of …
steen-klysner-jpeg-1

Industry veteran Dr Steen Klysner appointed as Amarna’s new CEO

September 9, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amarna, appointments

Amarna Therapeutics has announced the appointment of a new Chief Executive Officer (CEO), hiring industry veteran Dr Steen Klysner to …
carter_percy

FibroGen names appointment for newly created Chief Scientific Officer role

September 8, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointments, fibrogen

FibroGen has created the new role of Chief Scientific Officer and appointed Dr Percy Carter to the position, it has …
molly_henderson

Advaxis Chief Financial Officer resigns

September 8, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Advaxis

Molly Henderson, the Chief Financial Officer and Executive Vice President of Advaxis, has announced her resignation that will take effect …
shutterstock_95714119

Meta-analysis reinforces efficacy of commercially available steroids in hospitalised COVID-19 patients

September 4, 2020 Medical Communications, Research and Development COVID-19, pharma, steroids

A new meta-analysis of seven studies worldwide investigating the benefit for commercially available steroid therapies in the treatment of COVID-19 …
images_1

Operation Warp Speed’s top doctor says coronavirus vaccine likely won’t be approved until after November

September 4, 2020 Medical Communications

Dr Moncef Slaoui, the leading doctor involved with Operation Warp Speed, has said it is unlikely a vaccine for the …
782px-golden_hamster_front_1

Johnson & Johnson’s vaccine candidate for COVID-19 has shown efficacy in a small group of Syrian golden hamsters

September 4, 2020 Medical Communications COVID-19, J&J, JJ

Johnson & Johnson’s vaccine candidate for COVID-19 has shown efficacy in a small group of Syrian golden hamsters.
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

September 4, 2020 Medical Communications

The top 10 news stories this week largely cover coronavirus, as Sanofi is halting clinical trials treating serious COVID-19 patients …
tiktok-5323005_960_720

J&J issues warning after teen dies from Benadryl TikTok challenge

September 3, 2020 Medical Communications

One teen has died after taking large amounts of the antihistamine Benadryl as part of a social media “challenge” on …
3dmammogram

University of Illinois at Chicago’s new breast cancer drug is safe and can halt disease progression, according to a Phase 1 trial

August 28, 2020 Medical Communications Cancer, Cancers, breast cancer

A new breast cancer drug, called TTC-352, can halt the spread of the disease and is safe according to a …
49720569077_fac396d536_b

US signs deal to buy 150 million rapid COVID-19 tests from Abbott

August 28, 2020 Medical Communications

The US government has signed a deal to buy Abbott’s rapid coronavirus test after the FDA gave it Emergency Use …
The Gateway to Local Adoption Series

Latest content